{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:27:11Z","timestamp":1794655631212,"version":"4.9.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007145","name":"Thoratec Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.amjcard.2018.02.046","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T18:01:43Z","timestamp":1521396103000},"page":"1524-1529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial)"],"prefix":"10.1016","volume":"121","author":[{"given":"Dariusz","family":"Dudek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sobczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Tr\u0119bacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Vesga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Granada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Zembala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Witkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas M.","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Ocha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-5076","authenticated-orcid":false,"given":"Artur","family":"Dziewierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"\u017bmudka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.02.046_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcin.2008.11.005","article-title":"A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience","volume":"2","author":"Dixon","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2009.08.003","article-title":"Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention","volume":"145","author":"Ferreiro","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0020","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2009.09.018","article-title":"Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry","volume":"54","author":"Sjauw","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ccd.23403","article-title":"Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry","volume":"80","author":"Maini","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0030","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intraaortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0035","first-page":"360","article-title":"Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock","volume":"22","author":"Thomas","year":"2010","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0040","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ccd.23465","article-title":"Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience","volume":"80","author":"Alli","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0045","first-page":"417","article-title":"High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience","volume":"23","author":"Schwartz","year":"2011","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.carrev.2012.01.003","article-title":"Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what?","volume":"13","author":"Shah","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0055","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1002\/ccd.22929","article-title":"The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention","volume":"82","author":"Kovacic","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4244\/EIJV4I3A60","article-title":"The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions: the six-year Rotterdam experience","volume":"4","author":"Vranckx","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0065","first-page":"254","article-title":"Circulatory support with Impella CP device during high-risk percutaneous coronary interventions: initial experience in Poland","volume":"12","author":"Dudek","year":"2016","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0070","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4244\/EIJ-D-15-00467","article-title":"Design and principle of operation of the HeartMate PHPTM (percutaneous heart pump)","volume":"13","author":"Van Mieghem","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCULATIONAHA.110.945055","article-title":"Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support","volume":"123","author":"Naidu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9149(99)00185-X","article-title":"Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction","volume":"84","author":"Brodie","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0085","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1067\/mhj.2003.14","article-title":"Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty","volume":"145","author":"Briguori","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ahj.2006.02.024","article-title":"Elective versus provisional intraaortic balloon pumping in unprotected left main stenting","volume":"152","author":"Briguori","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0095","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.amjcard.2006.03.036","article-title":"Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention","volume":"98","author":"Mishra","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCOUTCOMES.110.960385","article-title":"Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry","volume":"5","author":"Curtis","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2010.1190","article-title":"Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial","volume":"304","author":"Perera","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0110","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a metaanalysis of controlled trials","volume":"30","author":"Cheng","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0115","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","article-title":"Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0120","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.02.046_bib0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ahj.2006.05.031","article-title":"A randomized multicenter clinical study to evaluate the safety and efficacy of the Tandem Heart percutaneous ventricular assist device versus conventional therapy with intra-aortic balloon pumping for treatment of cardiogenic shock","volume":"152","author":"Burkhoff","year":"2006","journal-title":"Am Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918302820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918302820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T06:01:35Z","timestamp":1617170495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918302820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0002914918302820"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.02.046","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.02.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}